Ms. Emily Kay Voeller, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1300 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-2300 Fax: 701-780-4477 |
Sarah Schmitt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2205 |
Liz Kratochvil Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2200 |
Ms. Catherine A. Adams Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2230 |
Independent Communication Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 S 11th St, Grand Forks, ND 58201 Phone: 701-740-5740 Fax: 701-795-9760 |
Mrs. Jessica Tiffany Aberth, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5870 Wydown Dr, Grand Forks, ND 58201 Phone: 630-456-2432 |
Mrs. Kristy A Fitzgerald, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 121 N Washington St, Grand Forks, ND 58203 Phone: 701-739-5497 |
Mrs. Dawn S Boyd Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2205 Fax: 701-746-2475 |
Sandra Diane Carr Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3633 10th Ave N, Grand Forks, ND 58203 Phone: 701-795-9721 |
Ms. Shari M Weisz, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2230 |
Hannah Kathleen Dybwad, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 |
Laura Elise Vaughn Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2230 |
Michelle Schake Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3000 Cherry St, Grand Forks, ND 58201 Phone: 701-746-2265 Fax: 701-746-2266 |
Mrs. Barbara Catherine-hall Carlson, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2230 |
Alexandra Rumple, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1300 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 Fax: 701-780-4477 |
Lindsay Dawn Schulz, MS/CY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2016 S Washington St, Grand Forks, ND 58201 Phone: 701-775-8934 Fax: 701-757-4208 |
Mrs. Pamela Joan Hill, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 47th Ave S, Grand Forks, ND 58201 Phone: 701-746-2230 |
Ms. Chelsey J. Kjono, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2512 S Washington St Ste C, Grand Forks, ND 58201 Phone: 701-330-4818 Fax: 701-335-7242 |
Sarah Wocken, M.A., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 290 Centennial Dr, Stop 8040, Grand Forks, ND 58202 Phone: 701-777-4808 |
Danielle Swart, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2600 Demers Ave Ste 101, Grand Forks, ND 58201 Phone: 701-757-3045 Fax: 701-757-3046 |
News Archive
Recently, researchers from the Monash University and Monash Medical Centre, Clayton, Victoria, Australia, investigated whether peptide sensitization using BCG can produce cross-reactive T cells specific to SARS-CoV-2. Their study is published on the preprint server, medRxiv.
People with a history of stroke or diabetes who were given clot-busting drugs to break up blood clots after stroke fared better than those who did not receive the drugs, according to a study published in the November 16, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
Laboratory testing at the U.S. Centers for Disease Control and Prevention (CDC) has identified the bacteria Burkholderia pseudomallei in an aromatherapy spray -; the same type of bacteria that sickened four people in the United States earlier this year.
Lithera, Inc. today announced positive results from a Phase IIa clinical study of LIPO-102, its novel injectable combination of salmeterol xinafoate and fluticasone propionate for selective, non-ablative fat reduction. LIPO-102 was well-tolerated when administered weekly for 8 weeks into the subcutaneous abdominal fat of healthy subjects.
› Verified 8 days ago